Evolent Health, Inc. (EVH)

Market Cap	1.37B
Revenue (ttm)	2.46B
Net Income (ttm)	-104.23M
Shares Out	115.03M
EPS (ttm)	-0.91
PE Ratio	n/a
Forward PE	14.51
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,980,901
Open	12.16
Previous Close	12.35
Day's Range	11.91 - 12.37
52-Week Range	11.91 - 35.00
Beta	1.59
Analysts	Strong Buy
Price Target	28.90 (+141.84%)
Earnings Date	Nov 7, 2024

About EVH

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care wor...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jun 5, 2015
• Employees: 4,700
• Stock Exchange: NYSE
• Ticker Symbol: EVH
• Website: https://www.evolent.com

Financial Performance

In 2023, Evolent Health's revenue was $1.96 billion, an increase of 45.26% compared to the previous year's $1.35 billion. Losses were -$142.26 million, 642.3% more than in 2022.

Analyst Forecast

According to 10 analysts, the average rating for EVH stock is "Strong Buy." The 12-month stock price forecast is $28.9, which is an increase of 141.84% from the latest price.

Price Target

$28.9

(141.84% upside)

Analyst Consensus: Strong Buy